BioWorld

Read the top updates in medical technologies, therapeutics & clinical development news on BioWorld. Explore BioWorld now: bioworld.com/articles/topic… #LifeSciences #MedTech #MedicalTechnologies

.@paradromics partners with academics to accelerate #BCI development bioworld.com/articles/729761 #medtech

US lawmakers to Bhattacharya: Explain your answers bioworld.com/articles/729760 #biopharma @GOPHELP @HELPCmteDems @NIH

Lab-grown pig implant paves way to treat esophageal atresia bioworld.com/articles/729759 #biopharma #science #esophagealatresia #tissueengineering #tracheatransplants

Australia’s R&D reset puts biotech translation in focus bioworld.com/articles/729758 #biopharma #innovation #Australia

#Azstarys (re-)born with @CollegiumPharma’s #ADHD buy bioworld.com/articles/729757 #biopharma #deal

Synnovation’s PI3Kα inhibitor portfolio draws @Novartis in $3B #deal (free w/one-time registration) bioworld.com/articles/729756 #biopharma #breastcancer

#ADPD2026: Three inflection points to target Alzheimer’s disease (free w/ registration) #neurology #preclinical #research #science #news bioworld.com/articles/72971…

.@US_FDA, @NIH mark milestones toward reducing animal testing bioworld.com/articles/729565 #biopharma

.@embecta acquires @OwenMumford for £150M bioworld.com/articles/729744 #medtech #acquisition #drugdelivery

.@minimed secures FDA nod for next-gen #insulin pump bioworld.com/articles/729746 #medtech #diabetes

.@GSK’s IBAT inhibitor wins US FDA nod for cholestatic pruritus bioworld.com/articles/729745 #biopharma #FDAapproval #raredisease

Triple crown: T2D purse for @EliLillyandCo’s phase III #retatrutide? (free w/one-time registration) bioworld.com/articles/729742 #biopharma @EliLillyandCo #obesity #weightloss #type2diabetes #A1C

Kintor’s KX-826 meets phase III endpoints in #alopecia bioworld.com/articles/729749 #biopharma #clinicaltrials #China

Study: GLP-1RAs associated with less risk of mental illness getting worse bioworld.com/articles/729743 #biopharma #GLP1RA #mentalillness @karolinskainst

Crossbow raises $77M series B for T-cell mimicking antibodies bioworld.com/articles/729747 #biopharma #financing #TCE #cancer #antibody

#ESMOTAT26: Targeted radionuclide therapy on the rise bioworld.com/articles/729748 #biopharma #TargetedRadionuclideTherapy #PrecisionOncology #Theranostics #TranslationalResearch

#REpharmaUSA: Folding #AI into the gameplan to speed research, adoption bioworld.com/articles/729563 #biopharma

#340B provider finds new way into court over Rx price disputes bioworld.com/articles/729559 #biopharma @CMSGov @abbvie @AstraZeneca @Novartis @sanofi

Icotyde’s in; wave of switchers to oral #psoriasis Protagonist? bioworld.com/articles/729558 #biopharma #FDA @JNJNews @ProtagonistTx